Revenue forecasts are a critical indicator of a company's future performance. Jazz Pharmaceuticals' revenue projection coming in below the consensus estimate could disappoint investors, leading to a potential short-term negative impact on the stock price. However, the difference is relatively small, which might limit the extent of the negative reaction.